000 | 01057 a2200301 4500 | ||
---|---|---|---|
005 | 20250516094940.0 | ||
264 | 0 | _c20121016 | |
008 | 201210s 0 0 eng d | ||
022 | _a1873-2518 | ||
024 | 7 |
_a10.1016/j.vaccine.2011.09.061 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aO'Hagan, D T | |
245 | 0 | 0 |
_aThe mechanism of action of MF59 - an innately attractive adjuvant formulation. _h[electronic resource] |
260 |
_bVaccine _cJun 2012 |
||
300 |
_a4341-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xadministration & dosage |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfluenza Vaccines _xadministration & dosage |
650 | 0 | 4 |
_aPolysorbates _xadministration & dosage |
650 | 0 | 4 |
_aSqualene _xadministration & dosage |
700 | 1 | _aOtt, G S | |
700 | 1 | _aDe Gregorio, E | |
700 | 1 | _aSeubert, A | |
773 | 0 |
_tVaccine _gvol. 30 _gno. 29 _gp. 4341-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2011.09.061 _zAvailable from publisher's website |
999 |
_c21850234 _d21850234 |